Sharp Exchanges as Stem Cell Board Tables Future Funding Proposal
A plan to finance the California stem cell agency after its $3 billion runs out in 2017 was shunted aside today after it ran into sharp opposition and questions from several of the agency's governing board members.
Vice chairman Art Torres attacked the preparation of the report as "offensive" because none of the patient advocates on the board, of which h…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.